| Primary |
| Myocardial Infarction |
20.2% |
| Percutaneous Coronary Intervention |
18.7% |
| Acute Myocardial Infarction |
16.6% |
| Product Used For Unknown Indication |
8.3% |
| Drug Use For Unknown Indication |
7.4% |
| Ill-defined Disorder |
4.7% |
| Basilar Artery Occlusion |
2.9% |
| Acute Coronary Syndrome |
2.6% |
| Premedication |
2.6% |
| Antiplatelet Therapy |
2.3% |
| Anticoagulant Therapy |
2.1% |
| Embolism |
2.0% |
| Atrial Fibrillation |
1.7% |
| Blood Pressure Increased |
1.4% |
| Prophylaxis |
1.3% |
| Hypertension |
1.1% |
| Thrombolysis |
1.1% |
| Acute Pulmonary Oedema |
1.0% |
| Coronary Angioplasty |
1.0% |
| Angioplasty |
0.9% |
|
| Thrombocytopenia |
22.3% |
| Incorrect Route Of Drug Administration |
10.8% |
| Pericardial Effusion |
7.2% |
| Haemorrhage |
5.8% |
| Thrombosis In Device |
5.8% |
| Ventricular Fibrillation |
5.8% |
| Ventricular Tachycardia |
5.0% |
| Cerebral Haemorrhage |
4.3% |
| Haemorrhage Intracranial |
4.3% |
| Transient Ischaemic Attack |
3.6% |
| Vascular Operation |
3.6% |
| Cardiac Tamponade |
2.9% |
| Respiratory Failure |
2.9% |
| Vascular Pseudoaneurysm |
2.9% |
| Cerebrovascular Accident |
2.2% |
| Gastrointestinal Haemorrhage |
2.2% |
| Haematoma |
2.2% |
| Myocardial Infarction |
2.2% |
| Off Label Use |
2.2% |
| Pericardial Haemorrhage |
2.2% |
|
| Secondary |
| Acute Myocardial Infarction |
25.2% |
| Percutaneous Coronary Intervention |
21.1% |
| Myocardial Infarction |
20.9% |
| Drug Use For Unknown Indication |
6.6% |
| Ill-defined Disorder |
4.0% |
| Antiplatelet Therapy |
3.1% |
| Product Used For Unknown Indication |
3.0% |
| Aneurysm Repair |
2.3% |
| Basilar Artery Occlusion |
2.1% |
| Premedication |
1.7% |
| Acute Coronary Syndrome |
1.6% |
| Prophylaxis |
1.5% |
| Anticoagulant Therapy |
1.4% |
| Coronary Arterial Stent Insertion |
0.9% |
| Embolism |
0.9% |
| Thrombosis Prophylaxis |
0.9% |
| Thrombosis |
0.8% |
| Cerebrovascular Accident |
0.6% |
| Hypercholesterolaemia |
0.6% |
| Ischaemic Stroke |
0.6% |
|
| Death |
12.3% |
| Thrombocytopenia |
8.6% |
| Thrombosis In Device |
8.0% |
| Pericardial Effusion |
6.2% |
| Ventricular Tachycardia |
6.2% |
| Myocardial Infarction |
5.6% |
| Off Label Use |
5.6% |
| Incorrect Route Of Drug Administration |
4.9% |
| Intraventricular Haemorrhage |
4.9% |
| Ventricular Fibrillation |
4.9% |
| Haemorrhage |
4.3% |
| Cerebral Haemorrhage |
3.7% |
| Vascular Operation |
3.7% |
| Cerebrovascular Accident |
3.1% |
| Coronary Artery Bypass |
3.1% |
| Pericardial Haemorrhage |
3.1% |
| Pulmonary Haemorrhage |
3.1% |
| Respiratory Failure |
3.1% |
| Vascular Occlusion |
3.1% |
| Cardiogenic Shock |
2.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
27.7% |
| Acute Myocardial Infarction |
15.5% |
| Mycobacterium Avium Complex Infection |
11.8% |
| Angioplasty |
11.0% |
| Stent Placement |
9.5% |
| Acute Coronary Syndrome |
3.5% |
| Kawasaki's Disease |
2.9% |
| Prophylaxis |
2.7% |
| Percutaneous Coronary Intervention |
2.5% |
| Staphylococcal Infection |
2.5% |
| Product Used For Unknown Indication |
2.3% |
| Thrombosis Prophylaxis |
2.1% |
| Sedation |
1.0% |
| Catheterisation Cardiac |
0.8% |
| Coronary Artery Stenosis |
0.8% |
| Pain |
0.8% |
| Anticoagulant Therapy |
0.6% |
| Myocardial Infarction |
0.6% |
| Preoperative Care |
0.6% |
| Sedative Therapy |
0.6% |
|
| Thrombosis In Device |
34.3% |
| Nausea |
9.0% |
| Septic Shock |
6.0% |
| Thrombosis |
6.0% |
| Cardiogenic Shock |
4.5% |
| Anxiety |
3.0% |
| Cardiac Tamponade |
3.0% |
| Drug Interaction |
3.0% |
| Haematemesis |
3.0% |
| Kounis Syndrome |
3.0% |
| Myocardial Infarction |
3.0% |
| Respiratory Failure |
3.0% |
| Retroperitoneal Haematoma |
3.0% |
| Thrombocytopenia |
3.0% |
| Ventricular Fibrillation |
3.0% |
| Ventricular Septal Defect |
3.0% |
| Vomiting |
3.0% |
| Abdominal Pain |
1.5% |
| Acute Myocardial Infarction |
1.5% |
| Coagulation Time Prolonged |
1.5% |
|
